|
Title
|
|
|
|
Non-invasive biomarkers of acute rejection in kidney transplantation : novel targets and strategies
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| Kidney transplantation is considered the favored treatment for patients suffering from end-stage renal disease, since successful transplantation is associated with longer survival and improved quality of life compared to dialysis. Alloreactive immune responses against the donor kidney may lead to acute rejection of the transplant. The current diagnosis of renal allograft rejection mainly relies on clinical monitoring, including serum creatinine, proteinuria, and confirmation by histopathologic assessment in the kidney transplant biopsy. These parameters have their limitations. Identification and validation of biomarkers, which correlate with or predict the presence of acute rejection, and which could improve therapeutic decision making, are priorities for the transplantation community. There is a need for alternative, less invasive but sensitive markers to diagnose acute graft rejection. Here, we provide an overview of the current status on research of biomarkers of acute kidney transplant rejection in blood and urine. We specifically discuss relatively novel research strategies in biomarker research, including transcriptomics and proteomics, and elaborate on donor-derived cell-free DNA as a potential biomarker. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Frontiers in Medicine
| |
|
Publication
|
|
|
|
Lausanne
:
Frontiers media sa
,
2019
| |
|
ISSN
|
|
|
|
2296-858X
| |
|
DOI
|
|
|
|
10.3389/FMED.2018.00358
| |
|
Volume/pages
|
|
|
|
5
(2019)
, 7 p.
| |
|
Article Reference
|
|
|
|
358
| |
|
ISI
|
|
|
|
000455046100001
| |
|
Pubmed ID
|
|
|
|
30671435
| |
|
Medium
|
|
|
|
E-only publicatie
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|